Mass Spectrometry (MS) Services

Delve into biomarker discovery and drug development with Crown Bioscience’s next-generation proteomics services—leveraging 4D-DIA technology for deep, reproducible protein profiling and post-translational modification analysis.

Crown Bioscience

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Ease of Use
After Sales Service
Value for Money
Be the first to leave a review
Description

Next-Generation Proteomics Services for Comprehensive Biomarker Analysis

In the dynamic landscape of biomedical research, understanding the proteome—the entire set of proteins expressed by a system—is crucial for unraveling disease mechanisms, identifying biomarkers, and developing targeted therapies. Crown Bioscience offers cutting-edge proteomics services, harnessing advanced mass spectrometry technologies to provide deep, accurate, and reproducible protein analysis.

Key Technologies and Services:

  • 4D-DIA Quantitative Proteomics: Combining ion mobility as a fourth dimension with data-independent acquisition (DIA) strategies, this approach enhances sensitivity and depth of protein identification, enabling the detection of low-abundance proteins and providing comprehensive proteomic profiles .
  • 4D Phosphoproteomics: Specialized in identifying and quantifying phosphorylation events, this service employs immobilized metal affinity chromatography (IMAC) and ion mobility separation to achieve high-confidence phosphosite mapping, crucial for studying signaling pathways .
  • Post-Translational Modification (PTM) Analysis: Beyond phosphorylation, Crown Bioscience offers analysis of various PTMs, providing insights into protein function regulation and disease associations .

Applications:

  • Biomarker Discovery and Validation: Identify protein biomarkers for disease diagnosis, prognosis, and therapeutic targeting.
  • Mechanism of Action Studies: Elucidate how drugs interact with their targets and affect cellular pathways.
  • Drug Development Support: Assess drug efficacy and toxicity through comprehensive proteomic profiling.
  • Disease Mechanism Research: Investigate the proteomic alterations associated with various diseases to uncover underlying mechanisms.

Product Overview

Links

Buy Mass Spectrometry (MS) Services Read Reviews